nifedipine - CISMeF

Preferred Label : nifedipine;

MeSH definition : A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.;

CISMeF synonym : infedipin; AWD pharma brand of nifedipine; orion brand of nifedipine; nifedipine orion brand; pfizer brand of nifedipine; nifedipine pfizer brand; adcock ingram brand of nifedipine; KRKA brand of nifedipine; nifedipine KRKA brand; bayer brand of nifedipine; nifedipine bayer brand;

MeSH hyponym : Nifedipine Monohydrochloride; vascard; procardia; Bay-1040; cordipin; BAY-a-1040; adalat; procardia XL; corinfar; fenigidin; nifangin; Bay 1040; Bay1040; BAY a 1040; BAYa1040; Cordipine; Korinfar; Monohydrochloride, Nifedipine; Nifedipine-GTIS; Nifedipine GTIS;

MeSH CAS label : 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, dimethyl ester;

MeSH Related Number : nifedipine monohydrochloride; 21829-25-4 (Nifedipine); 60299-11-8;

Registry Number MeSH : 21829-25-4;

Related CAS MeSH : 60299-11-8 (Nifedipine monohydrochloride);

Wikipedia link : https://en.wikipedia.org/wiki/Nifedipine;

Codes EINECS : 244-598-3;

Is substance : O;

UNII : I9ZF7L6G2L;

InChIKey : HYIMSNHJOBLJNT-UHFFFAOYSA-N;

Details

Origin ID

D009543;

UMLS CUI

C0028066;

ATC code(s)
- atenolol and nifedipine [ATC Code]
- nifedipine [ATC Code]
- nifedipine and diuretics [ATC Code]
- nifedipine, combinations [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- dimethyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate monohydrochloride [Substance BNPC]
CISMeF manual mappings
- Nifedipine adverse reaction (disorder) [SNOMED CT concept]
- Nifedipine measurement (procedure) [SNOMED CT concept]
- nifedipine [Substance BNPC]
Currated CISMeF NLP mapping
- NIFEdipine [LOINC component]
- Nifedipine [ICD-11 Extension code]
- Nifedipine [ICHI extension code]
- Nifedipine [SMS substance]
- Nifedipine [NCIt concept]
- Nifedipine (substance) [SNOMED CT concept]
- nifedipine [SNOMED Notion]
Pharmacological action(s)
- calcium channel blockers [MeSH Descriptor]
- tocolytic agents [MeSH Descriptor]
- vasodilator agents [MeSH Descriptor]
Record concept(s)
- BAY-a-1040 [MeSH concept]
- Bay-1040 [MeSH concept]
- Nifedipine Monohydrochloride [MeSH concept]
- adalat [MeSH concept]
- cordipin [MeSH concept]
- corinfar [MeSH concept]
- fenigidin [MeSH concept]
- nifangin [MeSH concept]
- nifedipine [MeSH concept]
- procardia [MeSH concept]
- procardia XL [MeSH concept]
- vascard [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1,4-dihydro-2,6--dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic acid bis(2-cyanoethyl) ester [MeSH Supplementary Concept]
- 1,4-dihydro-2,6-dimethyl--4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl-1-methylethyl ester [MeSH Supplementary Concept]
- 1,4-dihydro-2,6-dimethyl-4-(2,4-dinitrophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester [MeSH Supplementary Concept]
- 1,4-dihydro-2,6-dimethyl-4-(3-methylphenyl)-3,5-pyridinedicarboxylic acid dimethyl ester [MeSH Supplementary Concept]
- 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester [MeSH Supplementary Concept]
- 1,4-dihydro-2,6-dimethyl-4-(4-methylphenyl)-3,5-pyridinedicarboxylic acid dimethyl ester [MeSH Supplementary Concept]
- 1,4-dihydro-2,6-dimethyl-4-(4-nitrophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester [MeSH Supplementary Concept]
- 1,4-dihydro-2,6-dimethyl-4--(3-nitrophenyl)pyridine-3-carboxylic acid-5-carboxylic methyl ester [MeSH Supplementary Concept]
- 2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic acid [MeSH Supplementary Concept]
- 2-(2-(2-(2-chloro-4-(6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenoxy)acetylamino)ethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester [MeSH Supplementary Concept]
- BAY-P 8857 [MeSH Supplementary Concept]
- BAY-k 9320 [MeSH Supplementary Concept]
- CD 832 [MeSH Supplementary Concept]
- DHM 9 [MeSH Supplementary Concept]
- Depin-E [MeSH Supplementary Concept]
- FR 7534 [MeSH Supplementary Concept]
- MPC 2101 [MeSH Supplementary Concept]
- OPC 13463 [MeSH Supplementary Concept]
- PPK-12 [MeSH Supplementary Concept]
- PPK-5 [MeSH Supplementary Concept]
- YC 170 [MeSH Supplementary Concept]
- YM 430 [MeSH Supplementary Concept]
- acebutolol, nifedipine drug combination [MeSH Supplementary Concept]
- antrolin [MeSH Supplementary Concept]
- benidipine hydrochloride [MeSH Supplementary Concept]
- darodipine [MeSH Supplementary Concept]
- dehydronifedipine [MeSH Supplementary Concept]
- dibudipine [MeSH Supplementary Concept]
- diethyl 1,4-dihydro-4-(3-(4-bromophenyl)-1-phenyl-1H-pyrazol-4-yl)-2,6-dimethyl pyridine-3,5-dicarboxylate [MeSH Supplementary Concept]
- diethyl 1,4-dihydro-4-(3-(4-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)-2,6-dimethylpyridine-3,5-dicarbo-xylate [MeSH Supplementary Concept]
- dimethyl 1,4-dihydro-4-(3-(4-nitrophenyl)-1-phenyl-1H-pyrazol-4-yl)-2,6-dimethylpyridine-3,5-dicarboxylate [MeSH Supplementary Concept]
- dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylate [MeSH Supplementary Concept]
- glycidipine [MeSH Supplementary Concept]
- mebudipine [MeSH Supplementary Concept]
- menidipine [MeSH Supplementary Concept]
- mepirodipine [MeSH Supplementary Concept]
- mesudipine [MeSH Supplementary Concept]
- nifedipine-co-dergocrine combination [MeSH Supplementary Concept]
- niludipin [MeSH Supplementary Concept]
- nilvadipine [MeSH Supplementary Concept]
- nitrosonifedipine [MeSH Supplementary Concept]
- ryodipine [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Drug-induced photosensitivity (disorder) [SNOMED CT concept]
- Product containing nifedipine (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- NIFEdipine [LOINC component]
- Nifedipine [ICD-11 Extension code]
- Nifedipine [NCIt concept]
- Nifedipine (substance) [SNOMED CT concept]
- Product containing nifedipine (medicinal product) [SNOMED CT concept]
- nifedipine [ATC Code]
- nifedipine [Substance BNPC]
- nifedipine [SNOMED Notion]
Validated automatic mappings to BTNT
- dimethyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate monohydrochloride [Substance BNPC]
- nifedipine [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients